Unum Therapeutics Inc. (UMRX): Price and Financial Metrics
UMRX Price/Volume Stats
Current price | $2.35 | 52-week high | $3.72 |
Prev. close | $2.34 | 52-week low | $0.29 |
Day low | $2.32 | Volume | 124,600 |
Day high | $2.41 | Avg. volume | 1,222,692 |
50-day MA | $2.60 | Dividend yield | N/A |
200-day MA | $1.26 | Market Cap | 99.80M |
UMRX Stock Price Chart Interactive Chart >
Unum Therapeutics Inc. (UMRX) Company Bio
Unum Therapeutics Inc., a clinical stage biopharmaceutical company, develops and commercializes immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. Its lead product candidate is the ACTR087 used in combination with rituximab, which is in Phase I clinical trials to treat adult patients with relapsed or refractory non-Hodgkin lymphoma. The company’s product portfolio also includes ACTR707 used in combination with rituximab that is in Phase I clinical trials to treat adult patients with r/r B cell non-Hodgkin lymphoma; ACTR087 used in combination with SEA-BCMA, which is in Phase I clinical trials for treating patients with r/r multiple myeloma; and ACTR707 used in combination with trastuzumab, which is in late preclinical development phase for treating HER2+ solid tumor cancers. It has strategic collaboration with Seattle Genetics, Inc. to identify, research, develop, and commercialize antibody-coupled T cell receptor therapies. The company was founded in 2014 and is based in Cambridge, Massachusetts.
UMRX Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching UMRX
Want to see what other sources are saying about Unum Therapeutics Inc's financials and stock price? Try the links below:Unum Therapeutics Inc (UMRX) Stock Price | Nasdaq
Unum Therapeutics Inc (UMRX) Stock Quote, History and News - Yahoo Finance
Unum Therapeutics Inc (UMRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...